フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Allergy Therapeutics PLC 19 December 2024 Allergy Therapeutics plc ("Allergy Therapeutics", or the "Group") Exercise of Options and...
Allergy Therapeutics PLC 17 December 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Block Listing Interim...
Allergy Therapeutics PLC 16 December 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Result of Annual General...
Allergy Therapeutics PLC 04 December 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Allergy Therapeutics...
ics PLC - Sussex, England-based biotechnology company - Treats its first patient in the third phase of its paediatric ...
Allergy Therapeutics PLC 27 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics", "ATL" or the "Group") Allergy Therapeutics...
Allergy Therapeutics PLC 25 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics Submits...
Allergy Therapeutics PLC 21 November 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Notice of 2024 Annual General...
Allergy Therapeutics PLC on Wednesday said it narrowed its loss during its most recent financial year despite a decli ...
Allergy Therapeutics PLC 06 November 2024 Allergy Therapeutics PLC ("Allergy Therapeutics" or the "Group") Audited Preliminary Results...
Allergy Therapeutics PLC on Monday revealed that the first candidates have been enrolled in its phase III paediatric ...
Allergy Therapeutics PLC 21 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics" or "the Group") Allergy Therapeutics commences...
Allergy Therapeutics PLC shares rallied on Wednesday after it announced a funding update with an alternative asset ma ...
Allergy Therapeutics PLC 16 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics", the "Group" or "Company") Update on funding...
Allergy Therapeutics PLC 01 October 2024 Allergy Therapeutics plc ("Allergy Therapeutics", the "Group" or "Company") Update on funding...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約